Natriuretic peptides in patients with heart failure
Horii, M.; Saito, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 84-87
2004
ISSN/ISBN: 0047-1852 PMID: 15506343 Document Number: 578180
Document emailed within 1 workday
Related Documents
Angelika Hammerer-Lercher; Puschendorf, B.; Mair, J. 2001: Cardiac Natriuretic Peptides: New Laboratory Parameters In Heart Failure Patients Clinical Laboratory 47(5-6): 265-277Rehman, S.U.; Januzzi, J.L. 2008: Natriuretic peptides for guiding heart failure therapy Comprehensive Therapy 34(1): 32-40
Lindstedt, G.ör. 2006: Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure Lakartidningen 103(12): 930
Matsumoto, T.; Wada, A.; Tsutamoto, T.; Omura, T.; Yokohama, H.; Ohnishi, M.; Nakae, I.; Takahashi, M.; Kinoshita, M. 1999: Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure American Journal of Physiology 276(6): H1935-H1942
Song, J.-p.; Shen, B.; Liu, Z.-h.; Jiang, W.-p. 2003: The changes of plasma levels of brain natriuretic peptides in evaluation of treatment responses in chronic heart failure Zhonghua Nei Ke Za Zhi 42(5): 306-308
Kobalava, D.; Kotovskaya, Y.V.; Villevalde, S.V.; Moiseev, V.S. 2015: Perspectives for the Blockade of the Renin-angiotensin-aldesteron System and Modulation of Natriuretic Peptides System in the Treatment of Arterial Hypertension and Heart Failure Kardiologiia 55(6): 72-81
Minamino, N. 1991: Biochemistry of natriuretic peptides--brain natriuretic peptide and its related peptides Seikagaku. Journal of Japanese Biochemical Society 63(2): 94-119
Stenner, E.; Buiatti, A.; Barbati, G.; Merlo, M.; Sinagra, G.; Biasioli, B. 2012: Comparative Evaluation of B-Type Natriuretic Peptide and Mid-Regional Pro-A-Type Natriuretic Peptide Changes from Admission to Discharge in Prognosis of Acute Decompensated Heart Failure Patients Clinical Laboratory 58(5-6): 585-589
Takahashi, H. 2007: Pathophysiology of heart failure and the biomarkers; brain natriuretic hormone as the class-1 recommendation by the new Japanese Guideline for Heart Failure Rinsho Byori. Japanese Journal of Clinical Pathology 55(12): 1088-1096
Yasumura, Y. 2004: Natriuretic peptides and valvular heart disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 93-94
Al-Meslmani, B.M.; Fahoum, S.K.; Shamia, M.G. 2005: N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure Saudi Medical Journal 26(11): 1695-1698
Cerra, M.C.; Gattuso, A. 1995: Natriuretic peptides binding sites in the vertebrate heart Bollettino della Societa Italiana di Biologia Sperimentale 71(1-2): 41-60
Wang, F.; Li, W.; Huang, J.; Wang, L.; Bian, W-yan.; Pang, H-min.; Wang, Y.; Xu, Z-min.; Li, Y-shi. 2006: Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure Zhonghua Xin Xue Guan Bing Za Zhi 34(1): 28-32
Shao, L.-w.; Han, Y.; Wang, Z.-k.; Sun, J. 2005: The diagnostic application of bedside measurement of plasma brain natriuretic in patients with heart failure Zhonghua Nei Ke Za Zhi 44(2): 99-101
Sirithunyanont, C.; Leowattana, W.; Sukumalchantra, Y.; Chaisupamonkollarp, S.; Watanawaroon, S.; Chivatanaporn, B.; Bhuripanyo, K.; Mahanonda, N. 2003: Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases Journal of the Medical Association of Thailand 86(Suppl 1): S87-S95
Mazovets, O.L.; Trifonov, I.R.; Katrukha, A.G.; Gratsianskiĭ, N.A. 2009: Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months Kardiologiia 49(1): 34-38
Chan, W.Y.; Hruby, V.J. 1988: Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor Journal of Pharmacology and Experimental Therapeutics 246(2): 597-602
Boffa, G.Maria.; Zaninotto, M.; Bacchiega, E.; Nalli, C.; Forni, M.; Tiso, E.; Cacciavillani, L.; Razzolini, R.; Plebani, M. 2005: Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 125-132
Wang, S.; Qu, X.; Qu, Y.; Yu, Y.; Feng, W. 2014: The effect of B-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial Die Pharmazie 69(3): 212-216
Van den Kerkhof, J.J.; Van der Sande, F.M.; Leunissen, K.; Kooman, J.P. 2007: Are natriuretic peptides useful biomarkers in dialysis patients? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(6): 636-640